Silent acute appendicitis revealed by PET-CT during treatment with ipilimumab and nivolumab: a new immune-related adverse event
- 1 November 2020
- journal article
- letter
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 69 (11), 2409-2410
- https://doi.org/10.1007/s00262-020-02724-3
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With CancerJAMA Oncology, 2019
- Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 TrialJournal of Clinical Oncology, 2019
- Characteristics and treatment of new-onset arthritis after checkpoint inhibitor therapyPublished by BMJ ,2018
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2017